Get started

Princeton Medical Institute

ROR: 00qtj8f75
OpenAlex ID: I4210093554
O1–06–05: The novel BACE inhibitor MK‐8931 dramatically lowers CSF beta‐amyloid in patients with mild‐to‐moderate Alzheimer's disease
2013 · Mark Forman, Huub‐Jan Kleijn, et al. · Alzheimer s & Dementia · 42
PDF
A Prospective Study Comparing the Long-term Effectiveness of Injectable Risperidone Long-acting Therapy and Oral Aripiprazole in Patients with Schizophrenia.
2010 · Wayne Macfadden, Yi-Wen Ma, et al. · PubMed Central · 42
Sintering Aerogels
1998 · George W. Scherer, Sylvie Calas, et al. · Journal of Sol-Gel Science and Technology · 24
Update on Disease-Modifying/Preventive Therapies in Alzheimer’s Disease
2015 · Jeffrey T. Apter, Kuntal Shastri, et al. · Current Geriatrics Reports · 19
PDF
Prognostic value of plasma biomarkers for informing clinical trial design in mild-to-moderate Alzheimer’s disease
2025 · Yuqi Qiu, Diane M. Jacobs, et al. · Alzheimer s Research & Therapy · 6
PDF
Advantages of SiC Hi‐Nicalon or NLM 202 Fibers in SiC f –SiBC Composites
2005 · Séverine Darzens, Jean‐Louis Chermant, et al. · Journal of the American Ceramic Society · 6
New Horizons in Alzheimer Research from Amyloid and Beyond
2020 · Jeffrey T. Apter, Kaylee M. White · OBM Geriatrics · 1
PDF
A Comprehensive Report on AI and Data Protection Compliance
2026 · Khan, Masood · Zenodo (CERN European Organization for Nuclear Research)
Multiple Episodes of Full-Body Tremors: An Unexpected Adverse Effect during an Alzheimer's Disease Investigational Drug Study
2018 · Apter Jeffrey T, Billones Ivy A, et al. · International Journal of Neurodegenerative Disorders
PDF
Works count: 10
Citation count: 223
Year
Topic
Type